)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
4D Molecular Therapeutics
4D Molecular Therapeutics (FDMT) investor relations material
4D Molecular Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary17 Jun, 2026
Opening remarks and agenda
The meeting was held virtually to enhance participation, communication, and cost savings for stockholders and the company.
Attendees were introduced to the management team, board members, Inspector of Election, and independent auditor.
Rules of conduct and the meeting agenda were made available to participants upon joining.
Shareholder proposals
Three proposals were presented: election of three Class III directors until 2029, ratification of the independent auditor for 2026, and advisory approval of executive compensation.
No advance notice for director nominations was received, closing nominations.
Overview of voting outcomes
All three proposals were approved: election of directors, ratification of PricewaterhouseCoopers as auditor, and advisory approval of executive compensation.
Full vote tallies will be published in a Form 8-K filed with the SEC within four business days.
Stockholder director nominations received
Advisory vote results on executive compensation
Form 8-K filing deadline for vote tallies
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from 4D Molecular Therapeutics
- Late-stage gene therapy trials aim to transform retinal disease treatment with broad global impact.FDMT
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - Gene therapy 4D-150 targets lifelong vision benefit and reduced injections in wet AMD.FDMTJefferies Global Healthcare Conference 20263 Jun 2026
- Pivotal global trials advance a disruptive, lifelong gene therapy for retinal disease.FDMTRBC Capital Markets Global Healthcare Conference 202619 May 2026
- 4D-150's phase III progress and robust data position it as a potential game-changer in retinal gene therapy.FDMTBank of America Global Healthcare Conference 202613 May 2026
- 4D-150 delivers paradigm-shifting durability in retinal disease, reducing injections by over 90%.FDMTCorporate presentation8 May 2026
- $458M cash supports late-stage trials and operations into H2 2028 despite a $68.8M net loss.FDMTQ1 20268 May 2026
- Biotech seeks to raise up to $400M for gene therapy pipeline via flexible shelf registration.FDMTRegistration filing7 May 2026
- Virtual annual meeting to elect directors, ratify auditor, and hold say-on-pay vote.FDMTProxy filing28 Apr 2026
- Proxy covers director elections, auditor ratification, say-on-pay, and governance details.FDMTProxy filing28 Apr 2026
Next 4D Molecular Therapeutics earnings date
Q2 20267 Aug, 2026
4D Molecular Therapeutics
Next 4D Molecular Therapeutics earnings date
Q2 20267 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage